Profit Or Loss [Abstract]

Sopharma Trading AD - Filing #6022496

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Raw materials and consumables used
10 536 BGN
9 042 BGN
Employee benefits expense
83 095 BGN
80 841 BGN
Depreciation and amortisation expense
29 984 BGN
28 554 BGN
Other expenses, by nature
5 141 BGN
7 541 BGN
Profit (loss) from operating activities
40 341 BGN
16 462 BGN
Finance income
755,000 BGN
2 106 BGN
Finance costs
7 092 BGN
6 489 BGN
Profit (loss) before tax
12 393 BGN
9 437 BGN
Tax expense (income)
3 313 BGN
1 387 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
9 080 BGN
9 080 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
8 050 BGN
8 050 BGN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
26.0000
23.0000

Talk to a Data Expert

Have a question? We'll get back to you promptly.